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Tuesday , March 8, 2011 345aPulmonary hypertension (PH) leads to right-ventricular hypertrophy and
failure(RVF). RVF involves adverse remodeling of the ventricular extracel-
lular matrix(ECM). Recently we found that estrogen (E2) rescues PH-in-
duced RVF. Here we investigated the effects of E2 on ECM
homeostasis. To induce PH, rats were injected with monocrotaline. At
day21, when PH had established, rats either received E2 (E2-group) for
10 days or were left untreated to develop RVF (RVF-group). Some E2
treated rats were sacrificed at day 30, and some were kept 12 days after
E2-withdrawal until day 42 (E2-W-group). Echocardiography, immunohisto-
chemistry, Western Blot and RT-PCR were performed. The RVF-group de-
veloped severe PH and RV failure with significantly depressed RV ejection
fraction (RVEF=30.451.8%,n=8 vs. 65.151.7%,n=5 in control). E2-ther-
apy resulted in significant improvements in RVEF in E2-group
(61.550.8%,n=10) that further improved in E2-W(63.150.9%,n=6). Struc-
tural changes in RV were also observed in the RVF-group including fibro-
sis and re-expression of the ECM proteins Osteopontin (OPN) and
Osteocalcin(OCN). OPN and OCN transcripts were significantly upregulated
in RVF(4.5 and 2-fold, respectively). OCN protein was also upregulated 2-
fold in RVF. Interestingly, although OPN and OCN transcripts in E2-group
were similar to RVF, OPN transcripts and OCN protein levels in E2-W
were fully restored to their values in healthy controls. Upregulation of
OPN and OCN in RVF and their persistence in E2 suggest their role in
mitigating adverse ventricular remodeling. Next, we investigated possible
regulation of ECM-degrading enzymes A Disintegrin And Metalloproteinase
(ADAM)15 and ADAM17 in PH and by E2 therapy. Both ADAM tran-
scripts were significantly upregulated in RVF and E2(~2.5 and 2-fold, re-
spectively) and were restored to control levels in E2-W. These results
suggest that a short-term E2-therapy leads to reverse ECM remodeling
which could contribute to long-term functional improvements in the RV
even after removal of E2.
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Visualisation of the Cytoskeleton in Cardiac Myocytes from a Model of
Atrial Fibrillation
Peter Lipp, Sandra Ruppenthal, Anke Scholz, Jennifer Jung, Lars Kaestner.
Saarland University; Molecular Cell Biology, Homburg/Saar, Germany.
Recently, in a mouse model of atrial fibrillation (RacET mouse) we have
shown that ec-coupling in ventricular as well as atrial myocytes was majorly
disturbed. We identified structural remodeling of T-tubular membranes as
a significant underlying mechanisms. In the heart it is well known that in-
creases in Rac1-activity (a small GTPase of the Rho family) result in produc-
tion of reactive oxygen species. Besides this, in other cell systems, Rac1 can
also lead to re organization of cytoskeletal components. In this study we inves-
tigated which components of the cytoskeleton in cardiac myocytes are affected
by the overexpression of constitutively active Rac1 (RacET). For this we used
high-resolution confocal microscopy of fixed ventricular and left & right atrial
myocytes, that were isolated from age-matched FVBN (wt-control) and
RacET mice and probed for the following cytoskeletal and related proteins:
actin, alpha-actinin, tubulin, vinculin and desmin. In addition, selected dou-
ble-labeling of myocytes allowed for the analysis of the relationship between
the various components. Confocal stacks (stepsize 100-200 nm) were decon-
volved and 3D-reconstructed in IMARIS software (BitPlane, CH). We found
the actin cytoskeleton unaltered in ventricular and atrial myocytes while mi-
crotubules displayed distinct alterations in RacET ventricular cells. While
vinculin showed no differences in its cellular distribution, the important car-
diac cytoskeletal protein desmin was distributed away from the z-discs in
atrial myocytes from RacET mice and showed a more random and peripheral
localization. We suggest that desmin-phosphorylation might lead to this re-
distribution and might significantly contribute to cellular remodeling in atrial
fibrillation.
This work was supported by the DFG (KFO196) and the Medical Faculty
(HOMFOR).Platform AH: Membrane Protein Structure II
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Lipid-Protein Interactions: are in Vitro and in Vivo Studies Contradictory
Or Complementary?
Jean-Marie Ruysschaert, Cedric Govaerts.
Free University of Brussels, Brussels, Belgium.A classical strategy to understand lipid-protein interactions is to assay
structure and function of purified membrane proteins reconstituted in pro-
teoliposomes whose lipid composition, fluidity, membrane tension, and/or
curvature can be controlled. Based on this approach, we have recently pro-
posed that LmrP, a secondary transporter requires specific interactions be-
tween protein motifs and the lipid headgroup (1).Specifically, we
postulated that the polar moiety of phosphatidylethanolamine (PE) interacts
with one or several side chains of LmrP, this interaction being required to
allow sensing of the proton gradient, the energy source for transport. This
suggests that the protein has evolved one or more specific PE-binding mo-
tifs and that, although abundant in the bacterial membrane, PE acts as a co-
factor playing a structural and functional role akin to that of structural
water molecules in soluble proteins. An alternate approach has been devel-
oped where genetically modified bacterial strains have their lipid composi-
tion changed. Based on this new way to dissect lipid-protein interaction in
a native environment, it has been shown that the lactose permease, LacY,
exhibits transport activity when expressed in a mutant of E.coli where PE
is replaced by PC suggesting that it is the physical and chemical properties
of the lipid bilayer (rather than the hydrophilic moiety) that determine the
overall conformation of LacY required for transport (2). These opposite
views and interpretations will be discussed.
1) Hakizimana P, Masureel M, Gbaguidi B, Ruysschaert JM, Govaerts C.J Biol
Chem. 2008,283(14):9369-76
2) Bogdanov M, Heacock P, Guan Z, Dowhan W Proc Natl Acad Sci U S A.
2010 Aug 24;107(34):15057-62.
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The bacterial Twin-arginine translocation pathway is able to transport fully
folded proteins across membranes. In B. subtilis it consists only of two
components: TatCd, which serves as a receptor for the signal peptide,
and the pore forming unit TatAd, which occurs in high stoichiometric ex-
cess. According to circular dichroism TatA contains a transmembrane seg-
ment, an amphiphilic helix, and an unstructured C-terminus [1]. Its detailed
moelcular structure was resolved by solid-state NMR spectroscopy in ori-
ented bilayers [2]. A striking pattern on the monomeric protein surface al-
lowed us to assemble several units into protomers and into an open
oligomeric pore. The stability of these complexes was supported by all-
atom MD simulations and using structure-based modeling [3]. The observed
interactions suggest that a novel motif for folding and self-assembly motif
is present in this membrane-bound transport system, which allows revers-
ible pore formation. Our comprehensive three-dimensional model thus rec-
onciles for the first time TatA transport with a pore size of variable
diameter, which can open and close by an energetically feasible
mechanism.
[1] Mu¨ller, S.D., A.A. De Angelis, T.H. Walther, S.L. Grage, C. Lange, S.J.
Opella & A.S. Ulrich (2007) Biochim. Biophys. Acta 1768: 3071-3079
[2] Walther, T.H., S.L. Grage, N. Roth & A.S. Ulrich (2010) J. Am. Chem. Soc.,
in press
[3] Grage, S.L., T.H. Walther, M. Wolf, A. Vargiu, M.J. Klein, P. Ruggerone,
W. Wenzel, A.S. Ulrich (2010) submitted~
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Joanna S. Slusky, Susanna Seppa¨la¨, Pilar Lloris-Garcera´,
Gunnar von Heijne.
Stockholm University, Stockholm, Sweden.
The mechanism by which helical membrane proteins are inserted into the
cellular membrane remains unclear. It is known that membrane proteins
are inserted co-translationally into the lipid bilayer and that positively
charged residues in the loop regions of TM proteins are important topolog-
ical determinants. However, it is unclear whether those charges act strictly
locally– affecting only the nearest transmembrane helices– or act globally–
affecting the topology of the entire protein. We have found that the topol-
ogy of an Escherichia coli inner membrane protein with four or five trans-
membrane helices can be controlled by a single positively charged residue
346a Tuesday , March 8, 2011placed in different locations throughout the protein, including the very C-
terminus. Addition of a charged, cleavable signal peptide to the N-terminus
of the protein indicates that topology does not change after insertion into
the membrane. These observation point to an unanticipated plasticity in
pre-insertion membrane protein topology.1876-Plat
First Step in Folding of Nonconstitutive Membrane Proteins: Spontaneous
Insertion of a Polypeptide into a Lipid Bilayer and Formation of Helical
Structure
Alexander G. Karabadzhak1, Dhammika Weerakkody1, Mak S. Thakur1,
Michael D. Anderson1, Donald M. Engelman2, Oleg A. Andreev1,
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There are two questions we would like to address: 1) what is the molecular
mechanism of a polypeptide insertion into a lipid bilayer and formation of
transmembrane helix? 2) Are there any transient changes of a lipid bilayer
in process of a polypeptide insertion and folding? As a convenient system
we are studying pHLIP (pH (Low) Insertion Peptide) insertion into a mem-
brane and folding, which is modulated by pH. Previously we showed, that
insertion of pHLIP occurs in several steps, with rapid (0.1 sec) interfacial
helix formation followed by a much slower (100 sec) insertion pathway to
form a transmembrane helix. The reverse process of unfolding and peptide
exit from the bilayer core, which can be induced by a rapid pH jump from
acidic to basic, proceeds much faster than folding/insertion and through dif-
ferent intermediate states. We designed two truncated pHLIP-variants by re-
moving Asp and Glu residues from the C-terminus, which goes across
a membrane. Our kinetic studies indicate that truncated versions of pHLIP
insert across a membrane much faster than original (WT) sequence and
with less number of intermediate states. Thus, the rate of insertion directly
depends on probability of protonation of C-terminal Asp and Glu residues,
and translocation of the C-terminus across a bilayer. To understand what
are the structural intermediates along the folding pathway, we designed
three single-tryptophan pHLIP-variants, where a Trp residue is positioned
at the beginning, middle and end of the transmembrane part of the peptide.
To study changes, which might occur with a lipid bilayer in a process of
peptide insertion and folding, we employed SAXS (small-angle x-ray
scattering) technique. A new kinetic model of pHLIP insertion/exit will
be discussed.1877-Plat
Molecular Dynamics Simulations of the BM2 Proton Channel: Interac-
tions with Lipids and Detergents
Sarah L. Rouse, Mark S.P. Sansom.
University of Oxford, Oxford, United Kingdom.
Influenza viruses A and B contain M2 proton channels (A/M2 and BM2
respectively) that are vital for viral replication. Despite performing similar
roles, A/M2 and BM2 have little sequence similarity, apart from a common
HxxxW motif thought to be responsible for the pH-dependent channel gat-
ing. The A/M2 TM domain has been extensively studied, both experimen-
tally and computationally. It is structurally well-characterized with several
structures of the TM domain deposited in the Protein Data Bank. The struc-
tures were solved under various conditions using a range of techniques and
show that the A/M2 channel exists in multiple conformations. The only
structure of BM2 available is the recently-determined solution NMR struc-
ture of the full length BM2 protein (PDB id 2KIX); the first full length
proton channel structure to be determined. It is structurally of interest as
it was shown to form a coiled-coil tetramer. We have performed a series
of atomistic Molecular Dynamics simulations of the BM2 TM domain (res-
idues 1-33) under a range of conditions. The structure and dynamics of the
channel are compared in a lipid bilayer environment and in detergent mi-
celles (including 1,2-dihexanoyl phosphocholine, the detergent used in the
solution NMR study). These studies allow us to identify key lipid-/deter-
gent-protein interactions and compare the structural plasticity of BM2 to
that of A/M2. A further aspect of these simulations is the unbiased forma-
tion of membrane protein-detergent complexes (PDCs). Membrane proteins
are generally studied in detergent environments. However, relatively little is
known about these PDCs. These simulations provide further informationabout the distribution, interactions and dynamics of detergent molecules
within the PDC.
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Palmitoylation has recently been shown to stabilize m-opioid receptor
(MOR) homodimerization and receptor-G protein coupling. The MOR pal-
mitoylation site is located at the intracellular end of transmembrane helix 3
(TMH3) (C3.55(170)) rather than in the C-terminus. In work reported here,
we tested the hypothesis that a specific cholesterol interaction with palmi-
toylated C3.55(170) may enhance interactions at the MOR homodimer in-
terface. First, interactive docking studies were used to orient two MOR/
cholesterol protomers at the symmetric TMH4-TMH5 interface of mouse
dark state rhodopsin. Following energy minimization of the complex, the
MOR protomers were found to form an interface that involves N4.41,
I4.44, C4.48, I4.51, A4.55 and P4.59, with the cholesterol from protomer
A interacting with residues on protomer B and vice versa. Cholesterol
was found to contribute 24.7% to the total interaction energy at the dimer
interface. In order to explore the structure and dynamics of this unique cho-
lesterol binding site, two sets of NAMD molecular dynamics simulations
were then performed employing the CHARMM 27 all atom force field.
In the first set of simulations in a fully hydrated POPC bilayer, we exam-
ined the structure and stability of a cholesterol docked between palmitoy-
lated C3.55(170) and the MOR monomer. The structure, location and
motion of this cholesterol was monitored. In a second set of simulations,
the uniqueness of this binding site was tested with the MOR monomer
model embedded in a fully hydrated 30% cholesterol/POPC lipid bilayer.
Here the cholesterol molecules were randomly placed in the simulation
cell. In particular these simulations address the specificity (location/dura-
tion) of alternate cholesterol-mu opioid contact sites. Our initial results
suggest that the docked binding site at palmitoylated C3.55(170) is a loca-
tion for specific binding of cholesterol at MOR. [Support: KO5 DA021358
(PHR) and RO1 DA023905 (PYL)]
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Visualization of Dysferlin Self-Interaction Using Fluorescence Resonance
Energy Transfer and Fluctuation Correlation Spectroscopy
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Mutations in the dysferlin gene cause progressive muscle weakness and
muscle wasting. Previously dysferlin was found to play a key role in
the Ca2þ-activated membrane repair process of striated myocytes. How-
ever, it remains to be explored as to how dysferlin is involved in muscle
membrane repair. Here we report for the first time that dysferlin forms
a homodimer in living cells as well as in detergent-solubilized cell lysates.
Sucrose gradient fractionation experiments showed that endogenous dysfer-
lin from digitonin-solubilized skeletal muscle membranes migrated into
heavy fractions. A self-associated fluorescent protein labeled dysferlin
(ECFP-dysferlin and EYFP-dysferlin) complex in living AAV293 cells
and adult skeletal muscle fibers was demonstrated by fluorescence reso-
nance energy transfer (FRET) assay. Importantly, fluorescent protein tag
at the N terminus of dysferlin did not impair the function of dysferlin
in restoring the membrane repair efficiency in dysferlin-deficient skeletal
muscle fibers. FRET between ECFP-dysferlin and EYFP-dysferlin in skel-
etal muscle fibers showed hyperbolic dependence on protein concentration,
with a maximum efficiency of 35.3% and a very low KD. The observed
FRET corresponds to a probe separation distance of 54.4 A˚, according
to a computational model of dimeric FRET. Dysferlin dimerization was
further confirmed by using fluorescence fluctuation spectroscopy with pho-
ton counting histogram analyses. Moreover, myoferlin, a mammalian or-
thologue of dysferlin, also forms dimer. The heterodimeric affinity
between dysferlin and myoferlin is weaker than that of either homodimer.
Finally, the transmembrane domain was identified to mediate the dimeriza-
tion of dysferlin. Therefore, our data demonstrate that dysferlin forms a ho-
modimer in cells, which may be a common feature for ferlin-1-like protein
family.
